Brain Abnormalities in Patients with Germline Variants in H3F3: Novel Imaging Findings and Neurologic Symptoms Beyond Somatic Variants and Brain Tumors

References

1. 1.↵
   1. Mariño-Ramírez L,
   2. Kann MG,
   3. Shoemaker BA, et al

   . Histone structure and nucleosome stability. Expert Rev Proteomics 2005;2:719–29 doi:10.1586/14789450.2.5.719 pmid:16209651

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Zhao Z,
   2. Shilatifard A

   . Epigenetic modifications of histones in cancer. Genome Biol 2019;20:245 doi:10.1186/s13059-019-1870-5 pmid:31747960

   CrossRefPubMed
3. 3.↵
   1. Kim JH,
   2. Lee JH,
   3. Lee IS, et al

   . Histone lysine methylation and neurodevelopmental disorders. Int J Mol Sci 2017;18:1404 doi:10.3390/ijms18071404 pmid:28665350

   CrossRefPubMed
4. 4.↵
   1. Peter CJ,
   2. Akbarian S

   . Balancing histone methylation activities in psychiatric disorders. Trends Mol Med 2011;17:372–79 doi:10.1016/j.molmed.2011.02.003 pmid:21429800

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Bagchi RA,
   2. Weeks KL

   . Histone deacetylases in cardiovascular and metabolic diseases. J Mol Cell Cardiol 2019;130:151–59 doi:10.1016/j.yjmcc.2019.04.003 pmid:30978343

   CrossRefPubMed
6. 6.↵
   1. Sturm D,
   2. Witt H,
   3. Hovestadt V, et al

   . Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012;22:425–37 doi:10.1016/j.ccr.2012.08.024 pmid:23079654

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Aboian MS,
   2. Solomon DA,
   3. Felton E, et al

   . Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol 2017;38:795–800 doi:10.3174/ajnr.A5076 pmid:28183840

   Abstract/FREE Full Text
8. 8.↵
   1. Kurokawa R,
   2. Baba A,
   3. Kurokawa M, et al

   . Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: a case series and systematic review. J Neuroimaging 2022;32:17–27 doi:10.1111/jon.12939 pmid:34632671

   CrossRefPubMed
9. 9.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
10. 10.↵
    1. Bryant L,
    2. Li D,
    3. Cox SG, et al

    . Histone H3.3 beyond cancer: germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients. Sci Adv 2020;6:eabc9207 doi:10.1126/sciadv.abc9207 pmid:33268356

    FREE Full Text
11. 11.↵
    1. Garel C,
    2. Cont I,
    3. Alberti C, et al

    . Biometry of the corpus callosum in children: MR imaging reference data. AJNR Am J Neuroradiol 2011;32:1436–43 doi:10.3174/ajnr.A2542 pmid:21799035

    Abstract/FREE Full Text
12. 12.↵
    1. Jandeaux C,
    2. Kuchcinski G,
    3. Ternynck C, et al

    . Biometry of the cerebellar vermis and brain stem in children: MR imaging reference data from measurements in 718 children. AJNR Am J Neuroradiol 2019;40:1835–41 doi:10.3174/ajnr.A6257 pmid:31624120

    Abstract/FREE Full Text
13. 13.↵
    1. Marin-Padilla M,
    2. Marin-Padilla TM

    . Morphogenesis of experimentally induced Arnold–Chiari malformation. J Neurol Sci 1981;50:29–55 doi:10.1016/0022-510x(81)90040-x pmid:7229658

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Nishikawa M,
    2. Sakamoto H,
    3. Hakuba A, et al

    . Pathogenesis of Chiari malformation: a morphometric study of the posterior cranial fossa. J Neurosurg 1997;86:40–47 doi:10.3171/jns.1997.86.1.0040 pmid:8988080

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Poretti A,
    2. Ashmawy R,
    3. Garzon-Muvdi T, et al

    . Chiari type 1 deformity in children: pathogenetic, clinical, neuroimaging, and management aspects. Neuropediatrics 2016;47:293–307 doi:10.1055/s-0036-1584563 pmid:27337547

    CrossRefPubMed
16. 16.↵
    1. Schwartzentruber J,
    2. Korshunov A,
    3. Liu XY, et al

    . Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012;482:226–31 doi:10.1038/nature10833 pmid:22286061

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Weinberg DN,
    2. Allis CD,
    3. Lu C

    . Oncogenic mechanisms of histone H3 mutations. Cold Spring Harb Perspect Med 2017;7:a026443 doi:10.1101/cshperspect.a026443 pmid:27864305

    Abstract/FREE Full Text
18. 18.↵
    1. Khuong-Quang DA,
    2. Buczkowicz P,
    3. Rakopoulos P, et al

    . K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 2012;124:439–47 doi:10.1007/s00401-012-0998-0 pmid:22661320

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Feng J,
    2. Hao S,
    3. Pan C, et al

    . The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. Hum Pathol 2015;46:1626–32 doi:10.1016/j.humpath.2015.07.002 pmid:26297251

    CrossRefPubMed
20. 20.↵
    1. Castel D,
    2. Philippe C,
    3. Calmon R, et al

    . Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 2015;130:815–27 doi:10.1007/s00401-015-1478-0 pmid:26399631

    CrossRefPubMed
21. 21.↵
    1. Aboian MS,
    2. Tong E,
    3. Solomon DA, et al

    . Diffusion characteristics of pediatric diffuse midline gliomas with histone H3-K27M mutation using apparent diffusion coefficient histogram analysis. AJNR Am J Neuroradiol 2019;40:1804–10 doi:10.3174/ajnr.A6302 pmid:31694820

    Abstract/FREE Full Text
22. 22.↵
    1. Piccardo A,
    2. Tortora D,
    3. Mascelli S, et al

    . Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas. Eur J Nucl Med Mol Imaging 2019;46:1685–94 doi:10.1007/s00259-019-04333-4 pmid:31030232

    CrossRefPubMed
23. 23.↵
    1. Maze I,
    2. Wenderski W,
    3. Noh K-M, et al

    . Critical role of histone turnover in neuronal transcription and plasticity. Neuron 2015;87:77–94 doi:10.1016/j.neuron.2015.06.014 pmid:26139371

    CrossRefPubMed
24. 24.↵
    1. Deal RB,
    2. Henikoff JG,
    3. Henikoff S

    . Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones. Science 2010;328:1161–64 doi:10.1126/science.1186777 pmid:20508129

    Abstract/FREE Full Text
25. 25.↵
    1. Dion MF,
    2. Kaplan T,
    3. Kim M, et al

    . Dynamics of replication-independent histone turnover in budding yeast. Science 2007;315:1405–08 doi:10.1126/science.1134053 pmid:17347438

    Abstract/FREE Full Text
26. 26.↵
    1. Hennekam RC,
    2. Biesecker LG,
    3. Allanson JE, et al

    ; Elements of Morphology Consortium. Elements of morphology: general terms for congenital anomalies. Am J Med Genet A 2013;161A:2726–33 doi:10.1002/ajmg.a.36249 pmid:24124000

    CrossRefPubMed
27. 27.↵
    1. Doherty D,
    2. Millen KJ,
    3. Barkovich AJ

    . Midbrain and hindbrain malformations: advances in clinical diagnosis, imaging, and genetics. Lancet Neurol 2013;12:381–93 doi:10.1016/S1474-4422(13)70024-3 pmid:23518331

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Boycott KM,
    2. Flavelle S,
    3. Bureau A, et al

    . Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am J Hum Genet 2005;77:477–83 doi:10.1086/444400 pmid:16080122

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Bosemani T,
    2. Orman G,
    3. Boltshauser E, et al

    . Congenital abnormalities of the posterior fossa. Radiographics 2015;35:200–20 doi:10.1148/rg.351140038 pmid:25590398

    CrossRefPubMed
30. 30.↵
    1. Limperopoulos C,
    2. Soul JS,
    3. Gauvreau K, et al

    . Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics 2005;115:688–95 doi:10.1542/peds.2004-1169 pmid:15741373

    Abstract/FREE Full Text
31. 31.↵
    1. Messerschmidt A,
    2. Prayer D,
    3. Brugger PC, et al

    . Preterm birth and disruptive cerebellar development: assessment of perinatal risk factors. Eur J Paediatr Neurol 2008;12:455–60 doi:10.1016/j.ejpn.2007.11.003 pmid:18222715

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Steggerda SJ,
    2. Leijser LM,
    3. Wiggers-de Bruïne FT, et al

    . Cerebellar injury in preterm infants: incidence and findings on US and MR images. Radiology 2009;252:190–99 doi:10.1148/radiol.2521081525 pmid:19420320

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Barkovich AJ,
    2. Kuzniecky RI,
    3. Jackson GD, et al

    . Classification system for malformations of cortical development: update 2001. Neurology 2001;57:2168–78 doi:10.1212/wnl.57.12.2168 pmid:11785496

    CrossRefPubMed
34. 34.↵
    1. Barkovich AJ,
    2. Kuzniecky RI,
    3. Jackson GD, et al

    . A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873–87 doi:10.1212/01.wnl.0000183747.05269.2d pmid:16192428

    Abstract/FREE Full Text
35. 35.↵
    1. Shorvon S,
    2. Guerrini R,
    3. Trinka E, et al

    . The Causes of Epilepsy: Diagnosis and Investigation. Cambridge University Press; 2019
36. 36.↵
    1. Barkovich AJ,
    2. Guerrini R,
    3. Kuzniecky RI, et al

    . A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012;135:1348–69 doi:10.1093/brain/aws019 pmid:22427329

    CrossRefPubMedWeb of Science